Австралия - английский - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; povidone; lactose monohydrate; stearic acid; crospovidone - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Австралия - английский - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; stearic acid; lactose monohydrate; povidone; crospovidone - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Австралия - английский - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: povidone; lactose monohydrate; crospovidone; colloidal anhydrous silica; stearic acid; microcrystalline cellulose - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Австралия - английский - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: povidone; colloidal anhydrous silica; stearic acid; lactose monohydrate; microcrystalline cellulose; crospovidone - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Австралия - английский - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: povidone; colloidal anhydrous silica; crospovidone; lactose monohydrate; microcrystalline cellulose; stearic acid - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Австралия - английский - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: povidone; lactose monohydrate; crospovidone; colloidal anhydrous silica; stearic acid; microcrystalline cellulose - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: mannitol; microcrystalline cellulose; purified talc; citric acid; colloidal anhydrous silica - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: purified talc; mannitol; microcrystalline cellulose; citric acid; colloidal anhydrous silica - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - betahistine dihydrochloride - oral tablet - 16mg

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - betahistine dihydrochloride - oral tablet - 16mg